← Eichor
Condition: Hiv 1 Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hiv 1 Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The DART DELIVER-02 Study
Phase 1 · 3 location(s) · University of North Carolina, Chapel Hill · NCT07217379Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa
Phase 2 · 4 location(s) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Ot · NCT06205602Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therap
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT04160455A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Phase 2 · 123 location(s) · ViiV Healthcare · NCT07202546Cannabis Use, Cognition, and the Endocannabinoid System in HIV
EARLY_Phase 1 · 1 location(s) · University of California, San Diego · NCT04883255Viral Infection of HSPC Impacts Hematopoiesis
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06458504Caspofungin for Pneumocystis Pneumonia in PLWHIV.
Phase N/A · 1 location(s) · Instituto Nacional de Enfermedades Respiratorias · NCT06691321A Phase Ⅱa Clinical Study of CL-197 Capsules
Phase 2 · 1 location(s) · Henan Genuine Biotech Co., Ltd. · NCT07308782Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
Phase 3 · 4 location(s) · Chang Gung Memorial Hospital · NCT06507059Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.C
Phase 1 · 6 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06796686A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test
NA · 3 location(s) · bioLytical Laboratories · NCT07563309Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184
Phase 1 · 1 location(s) · ViiV Healthcare · NCT07636928Triage Survey for Infectious Disease Eligibility
Phase N/A · 1 location(s) · Brooklyn Clinical Research · NCT06492187A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1
Phase 1/Phase 2 · 1 location(s) · ViiV Healthcare · NCT07275606Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
Phase 1/Phase 2 · 2 location(s) · University of Melbourne · NCT05187429#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-i
NA · 28 location(s) · Casper Rokx · NCT06900829HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
Phase 2 · 1 location(s) · Centre de Recherches et d'Etude sur la Pathologie Tropicale · NCT04513626Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
Phase 1/Phase 2 · 8 location(s) · ViiV Healthcare · NCT05674656Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
NA · 1 location(s) · Syracuse University · NCT06648629Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adult
Phase 3 · 3 location(s) · Gilead Sciences · NCT07682961Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Phase 2 · 2 location(s) · Massachusetts General Hospital · NCT06554717Impacts of HIV Treatment Regimens on Archived Drug Resistance
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07643948Observational PIC Destination Cohort
Phase N/A · 4 location(s) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Ot · NCT05985642Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05419024Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
Phase 2 · 17 location(s) · ANRS, Emerging Infectious Diseases · NCT05300035A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and Wi
Phase 1 · 6 location(s) · BioNTech SE · NCT07392372HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia
Phase N/A · 4 location(s) · Euresist Network GEIE · NCT06127290Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabin
Phase 4 · 1 location(s) · José Antonio Mata Marín · NCT06907056Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Pa
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00039689First Time in Human Study of Long Acting VH4524184 Formulations
Phase 1 · 3 location(s) · ViiV Healthcare · NCT06310551
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.